Numeta G13e
Active ingredient not listed in the SAHPRA register
Baxter Healthcare South Africa (Pty) Ltd
Registration
- Applicant
- Baxter Healthcare South Africa (Pty) Ltd
- Registrations
- 1
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Numeta g13e Each 300 ml activated 3 chamber bag contains ALANINE 0,75 g and ARGININE 0,78 g and ASPARTIC ACID 0,56 g and CYSTEINE 0,18 g and GLUTAMIC ACID 0,93 g and GLYCINE 0,37 g and HISTIDINE 0,35 g and ISOLEUCINE 0,62 g and LEUCINE 0,93 g and LYSINE (AS LYSINE MONOHYDRATE) 1,03 g and METHIONINE 0,22 g and ORNITHINE(AS ORNITHINE HYDROCHLORIDE) 0,23 g and PHENYLALANINE 0,39 g and PROLINE 0,28 g and SERINE 0,37 g and TAURINE 0,06 g and THREONINE 0,35 g and TRYPTOPHAN 0,19 g and TYROSINE 0,07 g andVALINE 0,71 g and POTASSIUM ACETATE 0,61 g and CALCIUM CHLORIDE DIHYDRATE 0,55 g and MAGNESIUM ACETATE TETRAHYDRATE 0,10 g and SODIUM GLYCEROPHOSPHATE HYDRATED 0,98 g and GLUCOSE ANHYDROUS (AS GLUCOSE MONOHYDRATE) 40,0 g and REFINED OLIVE OIL (APPROXIMATELY 80 %) + REFINED SOYA BEAN OIL (APPROXIMATELY 20 %) 7,5 | Not listed | 52073952/25/0739 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
No structure available
The SAHPRA register lists no active ingredient for this product, so there is no compound to show.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.